XML 102 R87.htm IDEA: XBRL DOCUMENT v3.3.1.900
SEVERANCE AGREEMENTS (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Feb. 13, 2015
Jan. 09, 2015
Oct. 13, 2014
Sep. 15, 2014
Dec. 31, 2014
Dec. 31, 2014
Sep. 30, 2014
Chief Financial Officer | Separation Agreement              
Severance Agreement [Line Items]              
Target bonus percentage       100.00%      
Accrued severance expense             $ 0.1
Chief Executive Officer | Separation Agreement              
Severance Agreement [Line Items]              
Severance expense           $ 4.5  
Restricted shares | Chief Financial Officer | Separation Agreement              
Severance Agreement [Line Items]              
Accelerated vesting (in shares)       81,333      
Equity Option | Chief Executive Officer | Separation Agreement              
Severance Agreement [Line Items]              
Compensation expense related to cash severance, unpaid bonus and health insurance     $ 0.5        
Compensation expense related to accelerated vesting     1.1        
Selling, general and administrative expenses | Chief Financial Officer | Separation Agreement              
Severance Agreement [Line Items]              
Severance expense         $ 1.1    
Turing Pharmaceuticals              
Severance Agreement [Line Items]              
Upfront fees payment     $ 3.0     3.0  
Liabilities expected to be assumed         $ 3.0 3.0  
Severance expense and accrued severance expense           $ 2.9  
Turing Pharmaceuticals | Asset Purchase Agreement              
Severance Agreement [Line Items]              
Purchase price of assets   $ 1.0          
Sales value of product rights $ 1.1 $ 1.0          
Purchase Price Of Inventory 1.1            
Manchester Pharmaceuticals LLC              
Severance Agreement [Line Items]              
Sales value of product rights 0.7            
Manchester Pharmaceuticals LLC | Turing Pharmaceuticals              
Severance Agreement [Line Items]              
Sales value of product rights $ 0.3